RepliCel Life Sciences
Vancouver
About RepliCel Life Sciences
RepliCel is a regenerative medicine company with a focus on aesthetics and orthopedics. Its cell therapy products are tailor-made to restore cellular function rejuvenate aging or sun-damaged skin, regrow hair, and repair tendons. The company's dermal injection technology is designed to revolutionize aesthetic treatment outcomes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.8M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2024)
- Ticker: cve:RP
- Website: replicel.com
- Phone: 604-248-8730
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/replicel-life-sciences-163575 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.